BARK
Dog-products brand known for BarkBox subscriptions; latest-year revenue $395M per EightX.
- Best for
- Dog toys and subscriptions
- Price
- Ask for a quote
- Location
- United States
What BARK does
BARK sells themed dog toy and treat boxes on subscription (BarkBox, Super Chewer) plus dog products through its own site and retail partners. The EightX public DTC leaderboard (data checked October 2026) lists its latest fiscal-year revenue at $395 million. We could not confirm its latest fiscal 2026 figure directly before our research budget ran out.
Pricing
| Pricing model | Ask for a quote |
|---|---|
| Starting price | Ask for a quote |
From BARK's public pricing. Confirm current rates on their site.
Pros and cons
- Latest-year revenue $395M (EightX index)
- Subscription model gives recurring revenue
- Latest fiscal-year figure not confirmed directly
Services
Ratings
No verified reviews on BestAdAgency yet. Worked with BARK? Write the first review.
Verified client reviews
No verified reviews yet. Reviews are published after the reviewer confirms their work email and we check it.
Review BARK
Sources
Facts on this page come from public sources we checked on Oct 27, 2026. Spot something out of date? Send a correction.
Where BARK ranks
Ranking badges for BARK
Free to use on your website, proposals and email signature. The badge updates itself and links to your ranking.
BARK FAQs
What is BARK?
BARK is a dog-products brand known for BarkBox subscriptions; latest-year revenue $395M per EightX. Core services: Dog toy subscriptions, Dog treats, Dog products.
Who is BARK best for?
BARK is best for dog toys and subscriptions.
Where is BARK based?
BARK is based in United States.
What are the pros and cons of BARK?
Pros: latest-year revenue $395M (EightX index); subscription model gives recurring revenue. Cons: latest fiscal-year figure not confirmed directly.
What are the best BARK alternatives?
BestAdAgency ranks BARK #9 in Top 100 D2C Companies in the USA. Each of those lists compares BARK with its closest alternatives on results, specialty fit, pricing transparency and reviews.